A recent study conducted by researchers at Penn Medicine challenges the prevailing view that deceased donor liver transplants offer better survival rates compared to living donor transplants. Published in the journal Hepatology, the research analyzed national data from the Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) covering the years 2002 to 2012. The analysis included 2,103 living donor transplants and 46,674 deceased donor transplants.
Key findings indicate that the three-year patient survival rate for living donor transplants performed at experienced centers is 83%, compared to 78% for deceased donor transplants. This difference is more pronounced over a five-year period, with survival rates of 78% for living donor recipients versus 71% for their deceased donor counterparts. The study emphasizes the underutilization of living donor transplants, which can significantly reduce waitlist mortality, particularly for patients with specific conditions like autoimmune hepatitis or cholestatic liver disease.
In an effort to optimize donor-recipient matching, the Penn researchers developed a scoring system that categorizes recipients into high, intermediate, and low-risk groups based on various factors. This approach aims to enhance post-transplant outcomes, suggesting that improved matching could raise the three-year survival rates for well-matched pairs to over 87%.
With living donor transplants currently accounting for only 3-4% of all liver transplants, the researchers advocate for their increased adoption, particularly at centers with substantial experience like Penn. Given the urgent need for donor organs—with 20-30% of patients dying while waiting for a transplant—this study has important implications for clinical practice, donor selection, and public health policy regarding liver transplantation.
Source: www.sciencedaily.com
